Serologic profile of toxoplasmosis in pregnant women from a public hospital in Porto Alegre;Perfil sorológico para toxoplasmose em gestantes de um hospital público de Porto Alegre

Revista Brasileira de Ginecologia e Obstetricia

Volumn 28, Issue 3, 2006, Pages 158-164

  Reis, Myrian Morussi ^a,b,c   Tessaro, Maria Madalena ^a   D'Azevedo, Pedro Alves ^b  

^a Hospital Materno Infantil Presidente Vargas   (Brazil)

^b UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^c FFFCMPA ^*  (Brazil)

Author keywords

Congenital; IgG avidity; Pregnancy complications, infectious; Prevention; Serologic tests; Serology; Toxoplasmosis

Indexed keywords

EID: 33748898702     PISSN: 01007203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counseling. Lancet. 1999;353(9167):1829-33.
2. Lopez, Dietz VJ, Wilson M, Navin TR, Jones JL.. Preventing congenital toxoplasmosis. MMWR Recomm Rep. 2000;49(RR-2):57-75.
3. Bessières MH, Berrebi A, Rolland M, Bloom MC, Roques C, Cassaing S, et al. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests. Eur J Obstet Gynecol Reprod Biol. 2001;94(1):37-45.
4. Forestier F, Hohlfeld P, Sole Y, Daffos F. Prenatal diagnosis of congenital toxoplasmosis by PCR: extended experience. Prenat Diagn. 1998;18(4):407-9.
5. Lynfield R, Hsu HW, Guerina NG. Screening methods for toxoplasma and risk of disease. Lancet. 1999;353(9168):1899-900.
6. Robert-Gangneux F, Gavinet MF, Ancelle T, Raymond J, Tourte-Schaeffer C, Dupouy-Camet J. Value of prenatal diagnosis and early postnatal diagnosis of congenital toxoplasmosis: retrospective study of 110 cases. J Clin Microbiol. 1999;37(9):2893-8.
7. Wallon M, Liou C, Garner P, Peyron F. Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. BMJ. 1999;318(7197):1511-4.
8. Evengärd B, Petersson K, Engman ML, Wiklund S, Ivarsson SA, Tear-Fahnehjelm K, et al. Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect. 2001;127(1):121-7.
9. Lebech M, Andersen O, Christensen NC, Hertel J, Nielsen HE, Peitersen B, et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group. Lancet. 1999;353(9167):1834-7.
10. Ricci M, Pentimalli H, Thaller R, Ravà L, Di Ciommo V. Screening and prevention of congenital toxoplasmosis: an effectiveness study in a population with a high infection rate. J Matern Fetal Neonatal Med. 2003;14(6):398-403.
11. Lago EG, Neto EC, Melamed J, Rucksi AP, Presotto C, Coelho JC, et al. Neonatal screening for congenital toxoplasmosis in Porto Alegre, RS, Brazil. In: Proceedings of the International Conference on Toxoplasmosis; 2003 Jun 23-25; Copenhagen, Denmark. Copenhagen: The Panum Institute/University of Copenhagen; 2003. p. 40.
12. Petry LC, Tessaro MM, Guedes CR, Reis MM. Análise dos resultados da sorologia para toxoplasmose em gestantes do Hospital Materno-Infantil Presidente Vargas (HMIPV) em Porto Alegre, RS, utilizando a pesquisa de anticorpos específicos pelo ELFA, Sistema VIDASâ, bioMérieux. NewsLab. 2000;42:114-20.
13. Varella IS, Wagner MB, Darela AC, Nunes LM, Müller RW. Prevalência de soropositividade para toxoplasmose em gestantes. J Pediatr (Rio de J). 2003;79(1):69-74.
14. Montoya JC. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis. 2002;185 Suppl 1:S72-82.
15. Cimon B, Marty P, Morin O, Bessières MH, Marx-Chemla C, Gay-Andrieu F, et al. Specificity of low anti-Toxoplasma IgG titers with IMx and AxSYM Toxo IgG assays. Diagn Microbiol Infect Dis. 1998;32(1):65-7.
16. Camargo ME. Toxoplasmose. In: Ferreira AW, Ávila SLM, editores. Diagnóstico laboratorial das principais doenças infecciosas e auto-imunes. 2a ed. Rio de Janeiro: Guanabara-Koogan; 2001. p. 278-88.
17. Jenun PA, Stray-Pedersen B, Gundersen A-G. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J Clin Microbiol. 1997;35(8):1972-7.
18. Lappalainen M, Koskela P, Koskiniemi M, Ämmälä P, Hiilesmaa V, Teramo K, et al. Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J Infect Dis. 1993;167(3):691-7.
19. Ferreira AW, Camargo ME. Toxoplasmosis and the laboratory: diagnosis and a constant striving for improvement. Rev Inst Med Trop São Paulo. 2002;44(3):119-20.
20. Roberts A, Hedman K, Luyasu V, Zufferey J, Bessières MH, Blatz RM, et al. Multicenter evaluation of strategies for serodiagnosis of primary infection with Toxoplasma gondii. Eur J Clin Microbiol Infect Dis. 2001;20(7):467-74.
21. Segundo GR, Silva DA, Mineo JR, Ferreira MS. A comparative study of congenital toxoplasmosis between public and private hospitals from Uberlândia, MG, Brazil. Mem Inst Oswaldo Cruz. 2004;99(1):13-7.
22. Mozzatto L, Procianoy RS. Incidência de toxoplasmose congênita no sul do Brasil: estudo prospectivo. Rev Inst Med Trop São Paulo. 2003;45(3):147-51.